A heparin-like anticoagulant as part of global abnormalities of plasma glycosaminoglycans in a patient with transitional cell carcinoma. 1991

M K Horne, and E S Chao, and O J Wilson, and S J Scialla, and M A Lynch, and P J Kragel
Hematology Section, National Institutes of Health, Bethesda, MD 20892.

A patient is described in whom a circulating heparin-like anticoagulant developed during the terminal course of metastatic transitional cell carcinoma. The anticoagulant, which was identified as heparan sulfate, was the clinical sign of global abnormalities in the patient's plasma glycosaminoglycans. Subsequent analysis disclosed increased amounts of chondroitin sulfate as well as heparan sulfate. In addition, the charge density and molecular weight of the patient glycosaminoglycans and their organization into proteoglycans differed significantly from glycosaminoglycans isolated from normal plasma samples.

UI MeSH Term Description Entries
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D004588 Electrophoresis, Cellulose Acetate Electrophoresis in which cellulose acetate is the diffusion medium. Cellulose Acetate Electrophoreses,Cellulose Acetate Electrophoresis,Electrophoreses, Cellulose Acetate
D005260 Female Females
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M K Horne, and E S Chao, and O J Wilson, and S J Scialla, and M A Lynch, and P J Kragel
October 2009, Canadian Urological Association journal = Journal de l'Association des urologues du Canada,
M K Horne, and E S Chao, and O J Wilson, and S J Scialla, and M A Lynch, and P J Kragel
October 1991, Japanese circulation journal,
M K Horne, and E S Chao, and O J Wilson, and S J Scialla, and M A Lynch, and P J Kragel
June 1985, American journal of clinical pathology,
M K Horne, and E S Chao, and O J Wilson, and S J Scialla, and M A Lynch, and P J Kragel
July 1989, Blood,
M K Horne, and E S Chao, and O J Wilson, and S J Scialla, and M A Lynch, and P J Kragel
January 1991, La Revue de medecine interne,
M K Horne, and E S Chao, and O J Wilson, and S J Scialla, and M A Lynch, and P J Kragel
May 1990, Bratislavske lekarske listy,
M K Horne, and E S Chao, and O J Wilson, and S J Scialla, and M A Lynch, and P J Kragel
October 2018, International journal of dermatology,
M K Horne, and E S Chao, and O J Wilson, and S J Scialla, and M A Lynch, and P J Kragel
January 2018, Case reports in hematology,
M K Horne, and E S Chao, and O J Wilson, and S J Scialla, and M A Lynch, and P J Kragel
August 1989, The Journal of urology,
M K Horne, and E S Chao, and O J Wilson, and S J Scialla, and M A Lynch, and P J Kragel
April 1987, Thrombosis and haemostasis,
Copied contents to your clipboard!